Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 672

Results For "GE"

7603 News Found

U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib
Biotech | November 30, 2021

U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib

Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)


Galderma acquires ALASTIN Skincare to enhance its dermatology platform
Biotech | November 30, 2021

Galderma acquires ALASTIN Skincare to enhance its dermatology platform

ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio


DaVita research indicates effectiveness of mRNA vaccine in dialysis patients
News | November 30, 2021

DaVita research indicates effectiveness of mRNA vaccine in dialysis patients

Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively


Lupin launches learning platform for medical students
News | November 30, 2021

Lupin launches learning platform for medical students

Sciflix is a special Initiative by Lupin to assist future pulmonologists in staying abreast of the latest medical advances relevant to their speciality


RDIF believes that Sputnik vaccines can neutralise Omicron
News | November 30, 2021

RDIF believes that Sputnik vaccines can neutralise Omicron

According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2


Covishield effectiveness during the second wave at 63 per cent
Public Health | November 30, 2021

Covishield effectiveness during the second wave at 63 per cent

Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent


Govt reviews public health preparedness with states/UTs over Omicron
Policy | November 30, 2021

Govt reviews public health preparedness with states/UTs over Omicron

The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases


Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy
Biotech | November 30, 2021

Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy

Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab


Masimo Rad-G helps identify paediatric pneumonia in India
Medical Device | November 29, 2021

Masimo Rad-G helps identify paediatric pneumonia in India

Rad-G is a rugged, portable, handheld Masimo SET Measure-through Motion and Low Perfusion pulse oximeter and noninvasive respiration rate monitor


AMPATH launches its pathology laboratory in Mumbai
Clinical Trials | November 29, 2021

AMPATH launches its pathology laboratory in Mumbai

The company has has 10 existing labs in India